KLRK1 and acute myeloid leukemia: As DNA methylation has been associated with reduced expression of NKG2D ligands on AML cells and, conversely, exposure to azanucleosides can restore surface expression of these ligands [94], co-treatment with a drug such as azacytidine or decitabine may be a rational strategy to increase target density on AML cells.